// App-Quantinova.ai

60 : Preferences for colorectal cancer screening of physicians and individuals at average risk in the United States: A discrete choice experiment.

Researchers

Presenter

  • Sebastian Heidenreich

Principal Investigators

  • Lila J Finney Rutten

  • Lesley-Ann Miller-Wilson

  • Cecilia Moreno-Jimenez

  • Gin Nie Chua

  • Deborah Fisher

Medical Centers

  • Evidera, Inc., London, United Kingdom

  • Mayo Clinic, Rochester, MN

  • Exact Sciences Corporation, Madison, WI

  • Duke University College of Medicine, Durham, NC

Locations

  • United Kingdom

  • United States

Companies

  • Exact Sciences Corpo

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • 3β-hydroxysterol Δ24-reductase

  • Protein Tyrosine Phosphatase, Receptor Type N2

  • SEPT9 methylation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved